| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
7 |
| Employees |
1,115 |
| Revenues (TTM) (Millions $) |
103 |
| Net Income (TTM) (Millions $) |
-104 |
| Cash Flow (TTM) (Millions $) |
-54 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Athenex Inc. is an innovative pharmaceutical company that specializes in the development and commercialization of novel therapies for the treatment of cancer and other diseases. The company was founded in 2003 and primarily operates in the United States.
Athenex Inc. operates through three main segments: Oncology Innovation Platform, Commercial Platform, and Global Supply Chain Platform. The Oncology Innovation Platform focuses on the research and development of new drugs for the treatment of cancer. The Commercial Platform is responsible for marketing and sales of the products developed by the Oncology Innovation Platform, and the Global Supply Chain Platform oversees the manufacturing and distribution of these products.
The company has a broad pipeline of products in development, with a focus on oncology, including breast cancer, liver cancer, and bladder cancer. Athens has several proprietary drug delivery technologies, such as Orasolv and QrxPharmaceutics that improve the solubility and bioavailability of poorly soluble drugs.
Athenex Inc. has a strong commitment to international development, with a focus on emerging markets, particularly in Asia. The company has partnered with several leading pharmaceutical companies in China to develop and commercialize its cancer drugs.
Additionally, Athenex Inc. is also leading the race to develop a COVID-19 vaccine as the company has partnered with Bharat Biotech in India, the largest vaccine manufacturer, and the University of Hong Kong.
In summary, Athenex Inc. is a global pharmaceutical company that focuses on oncology treatments and drug delivery technologies. It has a strong commitment to emerging markets, particularly in Asia, and has a broad pipeline of products in development for the treatment of cancer and other diseases. The company is also leading the race to develop a COVID-19 vaccine.
Company Address: 1001 Main Street Buffalo 14203 NY
Company Phone Number: 427-2950 Stock Exchange / Ticker: NASDAQ ATNX
|
%
0.27%